CA3022354C - Procedes et compositions pour nanoparticules theranostiques - Google Patents

Procedes et compositions pour nanoparticules theranostiques

Info

Publication number
CA3022354C
CA3022354C CA3022354A CA3022354A CA3022354C CA 3022354 C CA3022354 C CA 3022354C CA 3022354 A CA3022354 A CA 3022354A CA 3022354 A CA3022354 A CA 3022354A CA 3022354 C CA3022354 C CA 3022354C
Authority
CA
Canada
Prior art keywords
hbpe
nanoparticle
psma
nanoparticles
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3022354A
Other languages
English (en)
Other versions
CA3022354A1 (fr
Inventor
Annette Khaled
Jesus Manuel Perez Figueroa
Santimukul Santra
Charalambos Kaittanis
Oscar Santiesteban
Jan Grimm
Hampton Sessions
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Memorial Sloan Kettering Cancer Center
University of Central Florida Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute, Memorial Sloan Kettering Cancer Center, University of Central Florida Research Foundation Inc filed Critical Sanford Burnham Prebys Medical Discovery Institute
Priority claimed from PCT/US2016/029804 external-priority patent/WO2016176462A1/fr
Publication of CA3022354A1 publication Critical patent/CA3022354A1/fr
Application granted granted Critical
Publication of CA3022354C publication Critical patent/CA3022354C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des compositions et des procédés pour identifier une cible de cellule de tumeur solide. L'invention concerne par ailleurs des compositions et des procédés de traitement du cancer de la prostate. L'invention concerne en outre des compositions thérapeutiques contre le cancer comprenant le peptide CT20p. Des nanoparticules qui sont conjuguées avec un ligand de ciblage qui est un substrat pour une protéine de cellule spécifique d'une tumeur solide sont également décrites.
CA3022354A 2015-04-28 2016-04-28 Procedes et compositions pour nanoparticules theranostiques Active CA3022354C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562153912P 2015-04-28 2015-04-28
US62/153,912 2015-04-28
PCT/US2016/029804 WO2016176462A1 (fr) 2015-04-28 2016-04-28 Procédés et compositions pour nanoparticules théranostiques

Publications (2)

Publication Number Publication Date
CA3022354A1 CA3022354A1 (fr) 2016-11-03
CA3022354C true CA3022354C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
US12097264B2 (en) Methods and compositions for theranostic nanoparticles
US20250049945A1 (en) Method of treatment for solid tumors containing hypoxia and/or stroma features
Kumar et al. Design of a small-molecule drug conjugate for prostate cancer targeted theranostics
Chen et al. Melanocortin-1 receptor-targeting ultrasmall silica nanoparticles for dual-modality human melanoma imaging
CN114377143A (zh) 用于诊断和治疗与表达cd206的细胞相关的病症的组合物、方法和药盒
Song et al. LyP-1-modified multifunctional dendrimers for targeted antitumor and antimetastasis therapy
US20220202950A1 (en) Compositions comprising bacterially derived intact minicells for theranostic applications
Kang et al. 64Cu-Labeled tetraiodothyroacetic acid-conjugated liposomes for PET imaging of tumor angiogenesis
Meher et al. Prostate-specific membrane antigen targeted deep tumor penetration of polymer nanocarriers
Jin et al. Positron emission tomography imaging of tumor angiogenesis and monitoring of antiangiogenic efficacy using the novel tetrameric peptide probe 64Cu-cyclam-RAFT-c (-RGDfK-) 4
US20250332265A1 (en) Psma targeted conjugate compounds and uses thereof
US20250222122A1 (en) Psma targeted conjugate compounds and uses thereof
WO2017192598A1 (fr) Stratégies de pré-ciblage pour l'imagerie moléculaire et/ou la radio-immunothérapie
AU2022410422A1 (en) Carbonic anhydrase ix ligands
US12186410B2 (en) Bi-dota complex-loaded dendritic polymer nanoparticles
Ma et al. Targeted Nanoprobes Enabled Precision Theranostics in Triple‐Negative Breast Cancer
CA3022354C (fr) Procedes et compositions pour nanoparticules theranostiques
CA3040257C (fr) Nanoparticules polymeres dendritiques chargees d'un complexe bi-dota
Xu et al. Synthesis, Characterization, Cellular Uptake, and
US20250387522A1 (en) Psma targeted pet and fluorescence imaging compounds
HK40062841A (en) Bi-dota complex-loaded dendritic polymer nanoparticles
Mei et al. Construction and application of prostate cancer-targeted PET/MRI contrast agent
de Freitas et al. Polymeric Nanoparticles for Theranostic Treatment of Cancer
HK40009372B (en) Bi-dota complex-loaded dendritic polymer nanoparticles
Hsieh Molecular Innovations Toward Theranostics of Aggressive Prostate Cancer